This treatment is for people whose illness got worse after they tried chemotherapy drugs that contain platinum. Some examples of these chemotherapy drugs are cisplatin and carboplatin.
The FDA will decide whether to approve odronextamab, a treatment for relapsed or hard-to-treat follicular lymphoma, by July 30, 2025. If approved, it would join other medications like Rituxan and Gazyva, which are also used to treat this condition.
The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to
Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre.
Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught
Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative
In the pharmaceutical world, there’s a big competition to create the best obesity drugs, currently dominated by Novo Nordisk and
Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool
Here’s a simplified summary of the regulatory updates for various pharmaceutical products: 1. **Pfizer’s Elrexfio**: Recommended in England for multiple
Here’s a simplified summary of the recent news from Biogen, Novartis, Resalis Therapeutics, and Moderna: **Biogen**: The biotech company has
